Chronic psychosocial stress enhances long-term depression in a subthreshold amyloid-beta rat model of Alzheimer's disease Tran, Trinh, Srivareerat,et al.

Slides:



Advertisements
Similar presentations
Cognition enhancing or neuroprotective compounds for the treatment of cognitive disorders: why? when? which? Lockhart BP, Lestage PJ. January 2003.
Advertisements

Alzheimer’s Disease Savidra Lucatero, Vinita Mehrotra, Sabrina Rawlings, Jackie Wheeler, & Matt Zustiak.
Etiopathogenesis of Alzheimer's disease
The Aging Brain The brain changes with age The frontal cortex & hippocampus are critical to learning, memory, planning and other cognitive activities,
BME 482 Kevin Sylvestre.  35 million cases of Alzheimer’s disease (AD) in U.S. alone  Causes are widely studied  Leading theory- Amyloid Cascade Hypothesis.
ALZHEIMER’S DISEASE Erin Dancey. Overview Alzheimer’s is the most common cause of dementia in adult life and is associated with the selective damage of.
Alzheimer’s and Autoimmunity ~ Amyloid-β & Tau ~.
Developmental Health Psychology. Aging Primary Aging Primary Aging –“normal” senescence Secondary Aging Secondary Aging –“pathological” senescence.
Alzheimer’s Disease Nicotine’s relationship and contribution to dementia.
Alzheimer’s Disease Find group of ~4 students ~ 10 minutes Discuss the following personal family connection to AD (if willing only) observations/experiences.
ALZHEIMER’S AND DOWN’S SYNDROME
Alzheimer’s Disease: Genetics, Pathogenesis, Models, and Experimental Therapeutics.
Alzheimer’s Disease By: Ryan Triplett. Alzheimer’s The deterioration of intellectual capabilities, memory, judgment, and personality to the extent that.
Stress and Health (and the brain) Is stress a good thing?
Gender Difference in Alzheimer’s Disease Neuropathology EH Corder, E Ghebremedhin, M Taylor, DR Thal, TG Ohm, H Braak Dr. Senckenbergische Anatomie Department.
Chronic Nicotine Restores Normal Aβ Levels and Prevents Short-term Memory and E-LTP Impairment in Aβ Rat Model of Alzheimer’s Disease Marisa Srivareerat,
HOW CAN NEUROIMAGING HELP UNDERSTAND, DIAGNOSE, AND DEVELOP TREATMENTS FOR ALZHEIMER'S DISEASE? Part A – AD definition, neuropath? NUCLEAR MEDICINE GRAND.
The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. Susan A. Farr, et al.
ALZHEIMER’S DISEASE BY OLUFOLAKUNMI KEHINDE PRE-MD 1.
Biological Myths of Aging Memory declines drastically with age for all people. IQ declines drastically with age in all people. Learning becomes more difficult.
 emotional facial expressions ◦ evolutionary explanation.
Progress Report on Alzheimer’s Disease Taking the Next Steps NIA NIH.
Alzheimer’s Disease and Myelin Degeneration RE|NOUS Jasmine Toor Week 6 Winter 2014 Meeting.
Neuroprotective Effects of Memantine. Hippocampal slice cultures Brown et al., Soc. Neurosci 2003 Semi-chronic 3-NP toxicity in organotypic hippocampal.
Amnesia Syndromes Lesson 22. Wernicke-Korsakoff’s Syndrome n Deficits similar to H.M. l Anterograde l retrograde more severe n Cause: Long-term alcohol.
Molecular mechanisms of memory. How does the brain achieve Hebbian plasticity? How is the co-activity of presynaptic and postsynaptic cells registered.
VIII. NEURODEGENERATIVE DISEASES. - Are disorders characterized by the cellular degeneration of subsets of neurons that typically are related by function,
WHAT DO YOU REMEMBER ABOUT ALZHEIMER’S DEMENTIA?.
Introduction Alzheimer’s disease (AD) is a neurodegenerative disease associated with brain shrinkage and the loss of neurons, particularly cholinergic.
Alzheimer’s Disease -> The Disease of Darkness Varun Doshi.
Heather Kellogg March 6, 2013 Honors Psychology, Period 1
Aging Nervous System. Neurotrophic Factors Necessary for Maintenance of Neurons Neurotrophin function o Play role in development of NS o Interact with.
Progressive, degenerative disorder Attacks the brain's neurons Results in loss of memory, thinking and language skills, and behavioral changes Confusion.
Do you remember what you ate for dinner two days ago?
Triad of systems mediate response to stress.
Exercise Primes A Molecular Memory For Brain-Derived Neurotrophic Factor Protein Induction In The Rat Hippocampus N.C. Berchtold, et. Al.
CLINICAL AND RESEARCH MEMORY CENTER LARIBOISIERE HOSPITAL PARIS FRANCE UNIVERSITY OF PARIS DIDEROT INSERM UNIT 942 INVOLVEMENT OF PKR IN ALZHEIMER’S DISEASE.
ALZHEIMER’S WHAT IS IT – WHAT TO DO ABOUT IT. VIDEO
Dementia Care Wendy Burnett CNS for Older People.
Under the supervision of miklós jászberényi
High resolution MRI at 21.1 T of the hippocampus and temporal lobe white matter in the differential classification of Alzheimer’s Disease & Diffuse Lewy.
Cognitive Disorders Chapter 13 Nature of Cognitive Disorders: An Overview Perspectives on Cognitive Disorders Cognitive processes such as learning, memory,
A seminar on the effects of hormones on memory By Hamish Whistler.
Alzheimer’s Disease Today and Tomorrow First case reported in 1906 Reported by Alois Alzheimer Patient Augusta D. first treated at 46 years old Paranoia,
Alzheimer’s Disease: Advances and Hope Trey Sunderland, M.D. Chief, Geriatric Psychiatry Branch National Institute of Mental Health Bethesda, Maryland.
Apolipoprotein E and Gray Matter Loss in Mild Cognitive Impairment and Alzheimer’s Disease Spampinato MV, Goldsberry G, Mintzer J, Rumboldt Z Medical University.
Genetic aspects of Alzheimer disease Karolina Pesz, Błażej Misiak, Maria M. Sasiadek Department of Genetics Wroclaw Medical University, Poland.
Neuroprotective Effects of Memantine. Hippocampal slice cultures Brown et al., Soc. Neurosci 2003 Semi-chronic 3-NP toxicity in organotypic hippocampal.
HOW CAN NEUROIMAGING HELP UNDERSTAND, DIAGNOSE, AND DEVELOP TREATMENTS FOR ALZHEIMER'S DISEASE? Part B – AD and brain systems NUCLEAR MEDICINE GRAND ROUNDS.
Diseases and Disorders of the Nervous System. schizophrenia Characterized by psychotic episodes involving hallucinations & delusions Genetic & environmental.
Measuring the Effect of Silencing the APP gene and Stimulating the CaMKII Pathway on Synaptic Plasticity in Alzheimer’s Disease Harshita Nangunuri.
DEGENERATIVE DISEASES is a disease in which the function or structure of the affected tissues or organs will progressively deteriorate over time, whether.
Measuring the Effect of Silencing the APP gene and Stimulating the CaMKII Pathway on Synaptic Plasticity in Alzheimer’s Disease Harshita Nangunuri.
Alzheimer’s Disease and Cholesterol
Memory Deficiency & Memory
Memory Deficiency & Memory
Alzheimer’s Disease Dr. Usman Ghani CNS Block.
Alzheimer’s Disease.
Imaging AD Progression Amyloid Imaging Agents.
Long Term Effects of Concussions
Amnesia Syndromes Lecture 21.
Dementia Supischa Theerasasawat Eric Pfeiffer, M.D J. Wesson Ashford
Disorders with Complex Genetics
Nat. Rev. Neurol. doi: /nrneurol
Chapter 30 Delirium and Dementia
Acetylation Unleashes Protein Demons of Dementia
Volume 6, Issue 3, Pages (February 2014)
Scott A. Small, Karen Duff  Neuron 
Neurotransmitters.
Alzheimer’s Disease Dr. Usman Ghani Neuropsychiatry Block.
Presentation transcript:

Chronic psychosocial stress enhances long-term depression in a subthreshold amyloid-beta rat model of Alzheimer's disease Tran, Trinh, Srivareerat,et al. Khalil Khlifi Pharm D. Candidate 2012 University of Georgia, College of Pharmacy

Alzheimer's Disease Progressive, irreversible brain disorder that gradually destroys memory and cognitive abilities Clinically, patient's are seen to have marked memory loss and impairment of social and occupational functions Pathologically, it is characterized by the accumulation of amyloid- beta peptides and tau protein o Accumulation is caused by abnormally folded amyloid-beta and tau proteins o The plaques are made up of small peptides amino acids in length and deposit outside neurons o Tau is used to stabilize the microtubules and a chemical change causes it to be hyperphosphorylated and thereby creates neurofibrillary tangles and disintegrates the neuronal transport system

Stress and AD Genetic factors have a very definitive role on the progression of the disease but what does the effect of non-genetic factors have on progression of these patients? o Exposure to severe and/or prolonged stress challenges homeostasis mechanisms and may cause over-activation and dysregulation of stress-activated systems o These may lead to subsequent negative changes in the brain The hippocampus is particularly susceptible to stress functions and is one of the first regions to be affected by AD o The hippocampus is involved in learning and memory processes

Methods and Materials Adult male Wistar rats weighing g at the beginning of the experiment Housed in groups of 6 with free access to food and water in a temperature and light controlled environment 4 Treatment groups were designated in this study o Control o Stress o Sub-amyloid-beta (SAB) o Stress and sub-amyloid-beta (SSAB) The SAB and SSAB groups were infused with subpathogenic doses of AB1-42 The Control and Stress groups were infused with an inactive reverse peptide AB42-1

Methods and Materials Both SAB and SSAB were subjected to chronic psychosocial stress using a form of "intruder" stress o Rats were kept in the same cages for 1 week then 2 rats were swapped in each cage daily for 6 weeks total  Stress was measured by marked increases in corticosterone levels Hippocampal Dissection o Animals were killed under urethane anaesthesia and the right hippocampi was removed and the dorsal and vental sides of area CA1 were separated and placed in microcentrifuge tubes and stored at -80C until processed

Method and Materials Immunoblotting o Hippocampal tissue was placed in an isotonic buffered cocktail containing protease and phosphatase inhibitors o Following antibodies were used in the study  Amyloid precursor protein (APP)  Beta-site amyloid precursor protein cleaving enzyme (BACE)  p-CaMKII  CaMKII  Calcineurin  Brain-derived neutrotrophic fator  GAPDH antibody

Statistics Carried out with a two-way analysis of variance (ANOVA) followed by Tukey's post hoc test Minimum significance of p<0.05

ANOVA Provides statistical test of whether or not the means of several groups are all equal and therefore generalizes t-test to more than two groups o Doing multiple t-tests between 2 groups would result in an increased chance of committing a type I error (rejects a true null hypothesis)

Results Effects on chronic stress on long term depression (LTD) in subAB rats o Magnitude of LTD was similar in both control and subAB rats however it was significantly enhanced in the stress compared with the control and subAB rats as shown as a decline in fEPSP (field exictatory post-synaptic potential) slope  Control /- 1.97%  Stress /- 4.35%  SubAB /- 3.41% o The slope of fEPSP was significantly (<0.001) lower in SSAB than those in control, stress, and SAB groups

Results Levels of calcineurin during expression of LTD o The levels of calcineurin were markedly increased by 30 +/- 6% in stimulated stress group and 26 +/- 3% in SSAB compared to unstimulated control group Levels of p-CaMkII and total CaMKII during expression of LTD o Levels of p-CaMKII were significantly increased by 116+/- 31% in SAB and 125+/-47% in SSAB rats as compared to unstimulated control group o Significant increases in levels of CaMKII in all the stimulated groups as compared to the unstimulated groups Basal levels of APP o There was no significant change in the APP levels across all groups

Discussion Human studies have never revealed an association between the number of stressful or negative life events and the effects on cognitive decline However, studies involving those with AD have shown that increased cortisol levels with one APOE-4 allele showed poorer coginitive decline o The researchers agree with the above statement based on the data in this study that points towards accelerated cognitive impairment in chronic stress situations Chronic stress compounded with amyloid-beta causes an enhanced LTD shown in the SSAB group Total CaMKII was increased in all groups whereas p-CaMKII was only increased in the stress groups and the normal brain both work to reverse LTD but in the SAB and SSAB group it potentiated LTD

Discussion As the great majority of the cases of AD are of the late onset sporadic type, it is presumed that it may be triggered or accelerated by non-genetic risk factors, such as chronic stress Exposure to stress lead to an increase in LTD but was enhanced with the addition of amyloid-beta The exact mechanism of acceleration is still to be explained but there are currently 2 ideas o Excessive secretion or prolonged exposure to glucocorticoids increases neuronal vulnerability to age-related disease o Alter the processing and production of various AD-related proteins resulting in negative alterations in cognition and synaptic plasticity

Author's Conclusions

Resources 1."Analysis of Variance." Wikipedia, the Free Encyclopedia. Web. 08 Feb Alzheimer, Alois. "Alzheimer's Disease." Wikipedia, the Free Encyclopedia. Web. 08 Feb